307 related articles for article (PubMed ID: 26317168)
1. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
[TBL] [Abstract][Full Text] [Related]
2. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
Dyduch G; Okoń K; Pescarini E
Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
[TBL] [Abstract][Full Text] [Related]
3. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
4. Mast cell tryptase and chymase in the progress of cutaneous vasculitis.
Lipitsä T; Naukkarinen A; Harvima IT
Arch Dermatol Res; 2015 Dec; 307(10):917-24. PubMed ID: 26498154
[TBL] [Abstract][Full Text] [Related]
5. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
[TBL] [Abstract][Full Text] [Related]
6. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
7. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
[TBL] [Abstract][Full Text] [Related]
8. Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.
Gulubova MV
Clin Exp Metastasis; 2003; 20(7):611-20. PubMed ID: 14669792
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of tryptase in bovine cutaneous and tumor mast cells.
Welle MM; Proske SM; Harvima IT; Schechter NM
J Histochem Cytochem; 1995 Nov; 43(11):1139-44. PubMed ID: 7560896
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions.
Kankkunen JP; Harvima IT; Naukkarinen A
Int J Cancer; 1997 Jul; 72(3):385-8. PubMed ID: 9247277
[TBL] [Abstract][Full Text] [Related]
11. [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma].
Rygoł B; Kyrcz-Krzemień S; Pajiak J; Konicki P; Kowai E; Gasińska T
Pol Arch Med Wewn; 2007; 117(1-2):27-32. PubMed ID: 17642203
[TBL] [Abstract][Full Text] [Related]
12. Serum tryptase levels in melanoma patients: case-control study and review of the literature.
Paolino G; Moliterni E; Didona D; Cardone M; Lopez T; Garelli V; Richetta AG; Bottoni U; Cantisani C; Rossi A; Calvieri S
G Ital Dermatol Venereol; 2019 Feb; 154(1):18-25. PubMed ID: 28079340
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue.
Hermes B; Feldmann-Böddeker I; Welker P; Algermissen B; Steckelings MU; Grabbe J; Henz BM
J Invest Dermatol; 2000 Jan; 114(1):51-5. PubMed ID: 10620115
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor.
Tóth-Jakatics R; Jimi S; Takebayashi S; Kawamoto N
Hum Pathol; 2000 Aug; 31(8):955-60. PubMed ID: 10987256
[TBL] [Abstract][Full Text] [Related]
15. In situ detection of the mast cell proteases chymase and tryptase in human lung tissue using light and electron microscopy.
Beil WJ; Pammer J
Histochem Cell Biol; 2001 Dec; 116(6):483-93. PubMed ID: 11810190
[TBL] [Abstract][Full Text] [Related]
16. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
[TBL] [Abstract][Full Text] [Related]
17. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M
Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
[TBL] [Abstract][Full Text] [Related]
18. Mast cell tryptase and chymase in developing and mature psoriatic lesions.
Harvima IT; Naukkarinen A; Paukkonen K; Harvima RJ; Aalto ML; Schwartz LB; Horsmanheimo M
Arch Dermatol Res; 1993; 285(4):184-92. PubMed ID: 8342961
[TBL] [Abstract][Full Text] [Related]
19. The combined action of mast cell chymase, tryptase and carboxypeptidase A3 protects against melanoma colonization of the lung.
Grujic M; Paivandy A; Gustafson AM; Thomsen AR; Öhrvik H; Pejler G
Oncotarget; 2017 Apr; 8(15):25066-25079. PubMed ID: 28212574
[TBL] [Abstract][Full Text] [Related]
20. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells.
Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP
Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]